3-[[4-[(R)-[1-(2,6-dimethylphenyl)tetrazol-5-yl]-(3-ethenylphenyl)methyl]piperazin-1-yl]methyl]-1H-indole
C31H33N7 — CID 158053867
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[4-[(R)-[1-(2,6-dimethylphenyl)tetrazol-5-yl]-(3-ethenylphenyl)methyl]piperazin-1-yl]methyl]-1H-indole
3-[[4-[(R)-[1-(2,6-dimethylphenyl)tetrazol-5-yl]-(3-ethenylphenyl)methyl]piperazin-1-yl]methyl]-1H-indole (PubChem CID 158053867) has the molecular formula C31H33N7 and a molecular weight of 503.65 g/mol. Its IUPAC name is 3-[[4-[(R)-[1-(2,6-dimethylphenyl)tetrazol-5-yl]-(3-ethenylphenyl)methyl]piperazin-1-yl]methyl]-1H-indole.
Molecular Properties
| Compound Name | 3-[[4-[(R)-[1-(2,6-dimethylphenyl)tetrazol-5-yl]-(3-ethenylphenyl)methyl]piperazin-1-yl]methyl]-1H-indole |
|---|---|
| PubChem CID | 158053867 |
| Molecular Formula | C31H33N7 |
| Molecular Weight | 503.65 g/mol |
| Exact Mass | 503.28 |
| IUPAC Name | 3-[[4-[(R)-[1-(2,6-dimethylphenyl)tetrazol-5-yl]-(3-ethenylphenyl)methyl]piperazin-1-yl]methyl]-1H-indole |
| SMILES | C=Cc1cccc([C@H](c2nnnn2-c2c(C)cccc2C)N2CCN(Cc3c[nH]c4ccccc34)CC2)c1 |
| InChI | InChI=1S/C31H33N7/c1-4-24-11-8-12-25(19-24)30(31-33-34-35-38(31)29-22(2)9-7-10-23(29)3)37-17-15-36(16-18-37)21-26-20-32-28-14-6-5-13-27(26)28/h4-14,19-20,30,32H,1,15-18,21H2,2-3H3/t30-/m1/s1 |
| InChIKey | FJUNMPPPPKFACX-SSEXGKCCSA-N |
| XLogP | 5.31 |
| TPSA | 65.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 503.65 |
| LogP ≤ 5 | 5.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158053867 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.